sera – Page 54 – Communicable Diseases Research

Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2

Research Article

Published on 2021-06-242022-10-29
Journal: PLoS Pathogens [Category] COVID-19, MERS, SARS,

COVID-19 Infection, Reinfection, and Vaccine Effectiveness in Arizona Frontline and Essential Workers: Protocol for a Longitudinal Cohort Study

Protocol

Published on 2021-06-242022-10-29
Journal: JMIR Research Protocols [Category] COVID-19,

[키워드] Active surveillance Adults baseline calculated center Characteristics close contact collected Community Complete Contact contribute Control COVID-19 COVID-19 illness COVID-19 vaccination COVID-19 vaccine death demographic characteristics Demographic factors diagnostic dose Effect Effectiveness Emergency enrolled Enrollment Epidemiology Essential essential worker Essential workers expected first responders hcp Health Health care health care personnel Hispanic Identifier immune response immunologic response incidence include increased risk independent individual Infection intensity longitudinal molecular nasal swab nasal swabs natural infection objective Older Other participant Perceived risk Personal protective equipment prevention recruit report respiratory responders response Result risk rRT-PCR saliva specimen SARS-CoV-2 SARS-COV-2 infection sera serology seronegative seropositive specimen Spread stratified survey Symptom symptomatic and asymptomatic tested unique vaccination women worker
[DOI] 10.2196/28925 PMC 바로가기 [Article Type] Protocol

Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?

SARS-COV-2 신흥 변종의 면역 회피 : 지금까지 무엇을 배웠습니까?

Review

Published on 2021-06-222022-09-01
Journal: Viruses [Category] MERS, SARS, 변종, 진단,

[키워드] accumulation Alpha antibody B.1.1.7 B.1.351 B.1.617 B.1.617.2 Beta Characteristics close monitoring convalescent individual convalescent individuals COVID-19 COVID-19 pandemic Delta Diversity elicited epitope Epitopes Epsilon evade Evolutionary rate Gamma genetic diversity human population Immune escape immune evasion Infection Lineage monoclonal antibodies Mutation mutations neutralization neutralization capacity P.1 recipient recipients reduced RNA viruses SARS-CoV-2 sera Spike protein the spike protein therapeutic Transmission vaccination Vaccines Variability variant variant of concern variants VoC while
[DOI] 10.3390/v13071192 PMC 바로가기 [Article Type] Review

Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancer

Article

Published on 2021-06-212022-10-04
Journal: Cell Death & Disease [Category] 바이오마커,

The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom

영국에서 유행하는 SARS-CoV-2 변이체의 항원성

Immunology

Published on 2021-06-172022-09-11
Journal: Frontiers in Immunology [Category] MERS, SARS, 변종, 진단,

Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation

심각한 COVID-19와 관련된 뇌병증은 강한 신경염증에 대한 증거가 없는 신경혈관 단위 변화를 나타냅니다

Article

Published on 2021-06-162022-09-12
Journal: Neurology® neuroimmunology & neuroinflammation [Category] MERS, SARS, 진단,

[키워드] acute respiratory syndrome addition albumin alteration anti-SARS-CoV-2 category caused CCL2 checked chemokines Cohort Complication Concentration control patient coronavirus correlated COVID-19 COVID-19 patient cross-sectional CSF CXCL10 CXCL8 Cytokines direct infection disease disorder elevated exhibited Factor growth factor Growth factors hepatocyte growth factor highest highlight Immunoglobulin impairment IND Inflammation Inflammatory inflammatory mediator intensive care mechanism neurologic neurologic disorders Neurovascular Patient patients patients with COVID-19 present proinflammatory mediators Quantitative replication of SARS-CoV-2 reverse transcription PCR SARS-CoV-2 SARS-CoV-2 RNA SARS-CoV-2-specific antibodies sera serum severe COVID-19 Strong Symptom systemic or local tested unit upregulation variety Vascular endothelium
[DOI] 10.1212/NXI.0000000000001029 PMC 바로가기 [Article Type] Article

Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Reactive Antibodies: December 2019-January 2020

중증 급성 호흡기 증후군 코로나바이러스 2(SARS-CoV-2)-반응성 항체를 식별하기 위한 미국 헌혈의 혈청학적 검사: 2019년 12월-2020년 1월

Article

Published on 2021-06-152022-09-12
Journal: Clinical Infectious Diseases: An Official Publicat [Category] MERS, SARS, 진단,

[키워드] acute respiratory syndrome American Red Cross anti-SARS-CoV-2 antibodies antibodies antibody binding activity blocking activity Blood Blood donors cause center collected Connecticut Control coronavirus coronavirus 2 coronavirus disease COVID-19 determine donation Donor ELISA ELISAs enzyme-linked immunosorbent first identified case IgG and IgM introduced Massachusetts Microneutralization test Neutralizing activity occurred prevention reactive reactivity respiratory Rhode Island SARS-CoV-2 sera serologic specimens Spike protein Spread subsequent tested Testing the United State total Ig virus Washington Wuhan, China
[DOI] 10.1093/cid/ciaa1785 PMC 바로가기 [Article Type] Article

Seroprevalence of SARS-CoV-2 (COVID-19) exposure in pet cats and dogs in Minnesota, USA

미국 미네소타의 애완 동물 고양이와 개에서 SARS-COV-2 (COVID-19) 노출의 혈청 유병률

Research Article

Published on 2021-06-142022-09-01
Journal: Virulence [Category] SARS, 진단, 치료기술, 치료법,

[키워드] antibody Antigen antigens assays average canine cat cats caused coronavirus coronavirus SARS-CoV-2 Coronaviruses COVID-19 COVID-19 pandemic cross cutoff value detect dog early phase ELISA ELISAs enzyme enzyme-linked immunosorbent assay enzyme-linked immunosorbent assays Evidence evidence of exhibited experiment feline coronaviruses Households identify IgG antibodies IgG antibody neutralization antibodies Neutralization assay neutralizing activities Neutralizing activity pandemic Protein RBD RBD-specific antibodies RBD-specific antibody RBD-specific IgG reported SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 N protein SARS-CoV-2 nucleocapsid sensitivity sera seropositive seropositive sample seropositive samples Seroprevalence serum sample serum samples Seven specific antibodies specific IgG antibodies specificity Spike protein Spread stomatitis the SARS-CoV-2 the spike protein USA vesicular stomatitis vesicular stomatitis virus was used zoonoses
[DOI] 10.1080/21505594.2021.1936433 PMC 바로가기 [Article Type] Research Article

Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals

BNT162b2-mRNA 백신 접종 개인에서 우려되는 SARS-CoV-2 변이체의 돌파율 증가에 대한 증거

Article

Published on 2021-06-142022-09-10
Journal: Nature Medicine [Category] MERS, SARS, 변종,

[키워드] apprehension B.1.1.7 B.1.351 B.1.351 variant BNT162b2 BNT162b2 mRNA BNT162b2 mRNA COVID-19 vaccine BNT162b2 mRNA vaccine caused cohort study Complete controls COVID-19 vaccine distribution dose effective Effectiveness evade Evidence evidence of first dose genomic sequencing individual Infection laboratory assays mRNA nasopharyngeal swabs neutralization of BNT162b2 performed phylogenetics positive Prevent proportion reduced SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 variant second dose sera service single dose Spread tested vaccination Vaccine vaccinee vaccinees variants variants of concern Viral viral genome sequence viral infection Viral variants VoC VOCs
[DOI] 10.1038/s41591-021-01413-7 PMC 바로가기 [Article Type] Article

Relative COVID-19 Viral Persistence and Antibody Kinetics

Article

Published on 2021-06-132022-10-28
Journal: Pathogens [Category] COVID-19,